Quick summary: Dr. Matthew Zuch is a New Jersey-based licensed clinical psychologist and co-founder of NeuroBoost, a mental health clinic focused on Transcranial Magnetic Stimulation (TMS), a non-medication treatment option for adults experiencing treatment-resistant depression, OCD, anxiety, and other mental health disorders. Dr Zuch’s goals for NeuroBoost are to increase awareness of TMS as an evidence-based option for treatment-resistant mental health patients and improve treatment outcomes for those still struggling with depression, OCD, or anxiety. His clinical background also includes leadership and academic roles at NYU Langone, and NeuroBoost is based in Bloomfield, New Jersey.
Key Facts
| Fact | Detail |
| Name | Dr Matthew Zuch |
| Credential | Licensed clinical psychologist |
| Role | Co-founder, NeuroBoost |
| Clinic location | Bloomfield, New Jersey |
| Service area | Bloomfield, Montclair, Essex County, and Northern New Jersey |
| Prior affiliation | NYU Langone (leadership and academic roles) |
| Clinic focus | TMS therapy, a non-medication treatment option for adults with treatment-resistant depression, OCD, anxiety, and other mental health disorders |
| Dr. Zuch’s goals for NeuroBoost | Increase awareness of TMS as an evidence-based option for treatment-resistant mental health patients; improve treatment outcomes for those still struggling with depression, OCD, or anxiety |
| Private practice focus | Anxiety, depression, obsessive-compulsive disorder (OCD), related behavioral concerns |
| Typical treatment course | Weekday TMS sessions over approximately 4–6 weeks (individual candidacy determined by clinical evaluation) |
Who Is Dr Matthew Zuch?
Dr Matthew Zuch is a New Jersey-based licensed clinical psychologist and co-founder of NeuroBoost, a mental health clinic focused on transcranial magnetic stimulation (TMS), a non-medication treatment option for adults experiencing treatment-resistant depression, OCD, anxiety, and other mental health disorders. Dr Zuch’s goals for NeuroBoost are to increase awareness of TMS as an evidence-based option for treatment-resistant mental health patients and improve treatment outcomes for those still struggling with depression, OCD, or anxiety.
In his private practice, separate from NeuroBoost, Zuch also treats anxiety, depression, obsessive-compulsive disorder, and related behavioural concerns. His clinical background includes leadership and academic roles with NYU Langone.
What is NeuroBoost?
NeuroBoost is a mental health clinic co-founded by Dr Matthew Zuch, focused on transcranial magnetic stimulation (TMS), a non-medication treatment option for adults experiencing treatment-resistant depression, OCD, anxiety, and other mental health disorders. Dr Zuch’s goals for NeuroBoost are to increase awareness of TMS as an evidence-based option for treatment-resistant mental health patients and improve treatment outcomes for those still struggling with depression, OCD, or anxiety.
NeuroBoost is based in Bloomfield, New Jersey, and serves patients from Bloomfield, Montclair, and across Essex County, as part of a broader effort in Northern New Jersey to make specialized neuromodulation available within a conventional outpatient setting.
NeuroBoost describes its clinical process in four stages:
- Evaluation: Assessing candidacy for TMS
- Treatment mapping: Identifying the target brain regions for stimulation
- Structured TMS course: Typically weekday sessions over about 4–6 weeks
- Progress monitoring: Tracking response throughout treatment
What is TMS (transcranial magnetic stimulation)?
TMS is a non-surgical treatment that uses targeted magnetic pulses to stimulate specific areas of the brain, without anaesthesia. The FDA recognizes repetitive TMS (rTMS) as a treatment for major depressive disorder, including in patients who have not achieved satisfactory improvement from antidepressant medication.
Supporting evidence: An umbrella meta-analysis covering 28 previous meta-analyses found that rTMS produced significantly higher odds of response and remission than sham treatment in treatment-resistant depression:
- Odds ratio for response: 3.27
- Odds ratio for remission: 2.83
TMS also has evidence and regulatory indications beyond depression, including for OCD and smoking cessation, with research ongoing into other applications.
Why does Zuch’s work focus on treatment-resistant depression?
Treatment-resistant depression describes cases where patients continue to experience substantial symptoms despite multiple prior interventions, such as medication trials. This creates a difficult clinical situation that pushes clinicians to consider additional options. TMS is positioned within the evidence-based treatment landscape for this population: the FDA documentation identifies TMS among established approaches for treatment-resistant depression, rather than treating it as experimental.
Is TMS right for every diagnosis?
No. According to the clinical philosophy associated with Zuch’s work, technology like TMS is most effective when paired with careful assessment and individualized treatment planning. For patients exploring treatment-resistant OCD, treatment-resistant anxiety, or other treatment-resistant conditions, the relevant clinical question is whether a specific TMS protocol is suitable for that individual, not whether every diagnosis should automatically receive the same treatment. A psychiatrist referral may be appropriate when medication management and neuromodulation need to be coordinated together.
FAQs
- Who is Dr Matthew Zuch? Dr Matthew Zuch is a New Jersey-based licensed clinical psychologist and co-founder of NeuroBoost, a mental health clinic focused on transcranial magnetic stimulation (TMS), a non-medication treatment option for adults experiencing treatment-resistant depression, OCD, anxiety, and other mental health disorders. His goals for NeuroBoost are to increase awareness of TMS as an evidence-based option for treatment-resistant mental health patients and improve treatment outcomes for those still struggling with depression, OCD, or anxiety.
- What is NeuroBoost? NeuroBoost is a mental health clinic focused on transcranial magnetic stimulation (TMS), a non-medication treatment option for adults experiencing treatment-resistant depression, OCD, anxiety, and other mental health disorders. It is based in Bloomfield, New Jersey, and co-founded by Dr. Matthew Zuch.
- Where is NeuroBoost located? NeuroBoost is located in Bloomfield, New Jersey, and serves patients from Bloomfield, Montclair, and across Essex County.
- What conditions does NeuroBoost’s TMS treatment target? NeuroBoost’s TMS treatment is a non-medication option for adults experiencing treatment-resistant depression, OCD, anxiety, and other mental health disorders. TMS also has evidence and FDA indications related to smoking cessation.
- How long does a typical TMS treatment course take at NeuroBoost? NeuroBoost reports that many treatment courses involve weekday sessions over approximately four to six weeks, with individual candidacy determined through clinical evaluation.
- Is TMS FDA-approved? The FDA recognises repetitive TMS (rTMS) as a treatment for major depressive disorder, including for patients who have not achieved satisfactory improvement from antidepressant medication.
- What is Dr Matthew Zuch’s clinical background outside of NeuroBoost? Outside of NeuroBoost, Zuch maintains a private practice treating anxiety, depression, obsessive-compulsive disorder, and related behavioural concerns, and his background includes leadership and academic roles with NYU Langone.
Amelia Hart, a psychology graduate from the University of Hertfordshire, has a keen interest in the fields of mental health, wellness, and lifestyle.
